Related Experiment Video
Updated: Jun 6, 2026

A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus
Published on: June 23, 2022
A case of levetiracetam-induced thrombocytopenia
Roger Oghlakian1, Charles Nock, Mohamad Koubeissi
1Department of Neurology, University Hospitals Case Medical Center, Cleveland, Ohio, USA. roger.oghlakian@uhhospitals.org
Abstract:
Rare cases of levetiracetam-induced thrombocytopenia have been reported in the literature. We report a case of glioblastoma multiforme and partial epilepsy treated with levetiracetam with subsequent development of thrombocytopenia. After ruling out all other possible causes of a decreased platelet count, we conclude that levetiracetam was the cause of this adverse event.
Related Concept Videos
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Drug toxicity: Idiosyncratic Reactions
Drug Toxicity: Risk factors
Hepatic Encephalopathy
Antiepileptic Drugs: Glutamate Antagonists
Drug Toxicity: Dose-Dependent Reactions